Bradycardia in a pediatric population after sugammadex administration: case series
Braz. J. Anesth. (Impr.)
; 73(1): 101-103, Jan.-Feb. 2023. graf
Article
em En
| LILACS
| ID: biblio-1420643
Biblioteca responsável:
BR891.2
ABSTRACT
Abstract Sugammadex is a distinctive neuromuscular reversal drug that acts by encapsulating the neuromuscular relaxant molecule and dislodging it from its site of action. Sugammadex has been approved for pediatric patients over 2 years of age. Although arrhythmias have been reported, there is no report of adverse effects in healthy children, such as severe bradycardia requiring intervention. We report two cases of severe bradycardia immediately after the administration of sugammadex in healthy children. Our aim is to alert to the occurrence of one of the most severe adverse effects of sugammadex, in the healthy pediatric population as well.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Fármacos Neuromusculares não Despolarizantes
/
Bloqueio Neuromuscular
Limite:
Child
/
Humans
Idioma:
En
Revista:
Braz. J. Anesth. (Impr.)
Assunto da revista:
ANESTESIOLOGIA
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Portugal
País de publicação:
Brasil